Silvana Battaglia's departure as Chief Human Resources Officer of Cencora, Inc. was reported, effective July 12, 2026; the filing names no successor. As of November 6, 2026, Cencora, Inc. has reported 4 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 29, 2026 to September 25, 2026, naming 2 appointments and 2 departures (Form 8-K, June 15, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Cencora, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: In · Person: Robert E. Sanchez · Effective: 2026-10-01 · 8-K, 2026-09-25
- · In / out: Out · Person: Lorence H. Kim · 8-K, 2026-08-14
- · In / out: Out · Person: Silvana Battaglia · Role: Chief Human Resources Officer · Effective: 2026-07-12 · 8-K, 2026-06-15
- · In / out: In · Person: Eva C. Boratto · Role: Chief Financial Officer · Effective: 2026-06-29 · 8-K, 2026-05-29
Cencora, Inc. reported changes in 4 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-29 to 2026-09-25. They name 4 people, with 2 appointments and 2 departures. Every row below is cited to the filing it comes from, and this page adds each new change as Cencora, Inc. files it.
Also on the record for Cencora, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.3% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| July 29, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 11.59% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Cencora, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Cencora, Inc. and the records around it.
Cencora, Inc. elsewhere on the record
Companies that share a holder
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Cencora, Inc.
Get an email when Cencora, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cencora, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Cencora, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cencora, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-25 | In | 2026-10-01 | 8-K, 2026-09-25 | ||
| 2026-08-14 | Out | 8-K, 2026-08-14 | |||
| 2026-06-15 | Out | Chief Human Resources Officer | 2026-07-12 | 8-K, 2026-06-15 | |
| 2026-05-29 | In | Chief Financial Officer | 2026-06-29 | 8-K, 2026-05-29 |
Who leads Cencora, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Human Resources Officer: Silvana Battaglia, departure reported, effective 2026-07-12 (filed 2026-06-15). No successor is named in these filings.
- Chief Financial Officer: Eva C. Boratto, appointed, effective 2026-06-29 (filed 2026-05-29).
New leaders reset buying decisions — get the Full Report on Cencora, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Human Resources Officer at Cencora, Inc., with the record behind each one.
Find candidates like Chief Human Resources Officer at Cencora, Inc.Every change, in the filing's words
Appointed: Robert E. Sanchez, effective 2026-10-01
Director Appointment On September 24, 2026, the Board of Directors (the "Board") of Cencora, Inc. (the "Company") appointed Robert E. Sanchez to serve on the Board (the "Appointment"), effective October 1, 2026 (the "Effective Date").
- In connection with the Appointment, the Board increased from ten to eleven members in accordance with the Company's Amended and Restated Bylaws.
- Mr. Sanchez will receive the same benefits and compensation as the other non-employee directors on the Board pursuant to the Company's Compensation Policy for Non-Employee Directors, as described on pages 40 to 41 of the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on January 22, 2026.
- Cash compensation is paid on a quarterly basis and the non-employee director annual equity award will be pro-rated for the period beginning on the Effective Date and ending on the date of the Company's 2027 Annual Meeting of Stockholders.
Departing: Lorence H. Kim
On August 13, 2026, following the conclusion of the quarterly meeting of the Board of Directors (the "Board") of Cencora, Inc. (the "Company"), Lorence H. Kim, M.D., informed the Company of his intent to resign from the Board effective immediately.
- Dr. Kim's decision was made in connection with his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc. and his need to devote additional time to his professional responsibilities at that company.
- Dr. Kim has advised the Company that his resignation is not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- The Company thanks Dr. Kim for his dedicated service.
Departing: Silvana Battaglia, Chief Human Resources Officer, effective 2026-07-12
On June 15, 2026, Cencora, Inc. (the "Company") announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer of the Company effective July 12, 2026.
- Ms. Battaglia will serve in an advisory capacity through the end of 2026.
- Ms. Battaglia's decision to retire from her position was not the result of a disagreement on any matter related to the Company's operations, policies or practices.
- Ms. Battaglia will be succeeded by Samantha L. Hammock, who will join the Company as Executive Vice President and Chief Human Resources Officer effective July 13, 2026.
- Ms. Hammock most recently served as Executive Vice President and Chief Human Resources Officer of Verizon Communications Inc.
Appointed: Eva C. Boratto, Chief Financial Officer, effective 2026-06-29
On May 27, 2026, Cencora, Inc. (the "Company") announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the "Appointment"), effective June 29, 2026 (the "Effective Date").
- Ms. Boratto succeeds James F. Cleary, who will be retiring from his role as Executive Vice President and Chief Financial Officer as previously disclosed.
- Mr. Cleary will serve in an advisory capacity through the end of 2026.
- Ms. Boratto, age 59, most recently served as Chief Financial Officer of Bath & Body Works, Inc. since August 2023.
- Prior to that, she served as Chief Financial Officer of Opentrons Labwork Inc., a privately held life sciences company, from February 2022 to July 2023.
- She previously spent 12 years at CVS Health Corporation as Executive Vice President and Chief Financial Officer (2018 to 2021), Executive Vice President, Controller and Chief Accounting Officer (2017 to 2018), Senior Vice President and Chief Accounting Officer (2013 to 2017), and Senior Vice President for Pharmacy Benefit Management Finance (2010 to 2013).
- Earlier in her career, Ms. Boratto spent 20 years at Merck & Co., Inc. in a number of leadership roles, including Vice President U.S. Market Finance Leader.
- Ms. Boratto serves on the board of directors of Mars, Inc., where she is Chair of the Audit Committee, and currently serves on the board of directors of United Parcel Service, Inc., where she is Chair of the Audit Committee.
- Ms. Boratto earned a Master of Business Administration from Drexel University and a Bachelor of Science in Accounting and Economics from Rutgers University.
Tools for this story
Each opens in a new tab, filled in for Cencora, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.